REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/06/2026
Back to search
Official data from USPTO
LIFELABS GENETICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000087246841Class
1, 5, 9, 35, 38, 42, 44
Filing
87246841
Registration
6311559
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
76
Latest update
04/07/2026
Trademark type
Combined
Nice classes
1, 5, 9, 35, 38, 42, 44
Filing date
11/23/2016
Registration date
04/06/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/06/2021
Last transaction
04/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
13
Owner location
Toronto, Ontario, CA
Examiner
GARDNER, DAWNA BERYL
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "LIFELABS" above the stylized wording "GENETICS". The letter "I" in "LIFE" is composed of a stylized stick person with a dot for a head. The letter "I" in "GENETICS" is a letter "I" inside of a circle.
Holders and representatives
Holders
L. L. (pessoa física)
Representatives
Nicholas G. de la Torre Neal & McDevitt, LLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 35Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemically treated non-medical test strips for calibration of laboratory test equipment and medical diagnostic equipment; diagnostic preparations for medical laboratory use; diagnostic reagents for clinical and medical laboratory use; assays and reagents for use in genetic research; genetic identity tests comprised of reagents for non-medical purposes; reagents for scientific or medical research use; chemical reagents for non-medical purposes
Class 5
drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of lipidscarbohydratesproteinsenzymesacidsalcoholsmetabolitesvitaminselectrolytesheavy metalscontaminantspoisonstoxins; diagnosticpreparations for medical research use; medical diagnostic reagents; diagnostic kits comprised of organic and inorganic medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; biological preparations for detecting genetic predispositions for medical purposes; newborn screeningsgenetic identity tests comprised of reagents for medical purposes; newborn screeningspreparations for detecting somatic mutation in genes for medical purposes; newborn screeningspreparations for detecting autoimmune diseases in genes for medical purposes; newborn screeningspreparations for detecting epigenetic disorders in genes for medical purposes; newborn screeningsmedical diagnostic test strips for blood analysis; diagnostic biomarker reagents for analysis of genetic sequencing for medical purposes; diagnostic biomarker reagents for analysis of metabolic disorders for medical purposes; diagnostic biomarker reagents for analysis of enzyme deficiency for medical purposes
Class 9
Aliquottersmanual and robotic devices for use in medical laboratories to accurately dispense liquid volumes of medical patient samples and reagents into separate specimen containers; filters for blood and blood components for laboratory use; laboratory devices implementing nucleic acid extractionfluorescence in situ hybridization and competitive hybridization to detect genetic sequences; scientific instrumentsanalyzers for detecting and karyotyping chromosomes; computer software for scientific analysis of genetic sequences; computer software platform for analyzing bioinformatics to interpret results of genetic testing; computer software platforms for use in generating clinical reports for genetic testing; computer communications software for connecting medical practices via the Internet to manage and share patient information relating to genetic testing orders and results; computer programs for managing requests for genetic testinglaboratory processing and laboratory equipment; computer programs for controlling quality of testing and integrity of testing results
Class 35
data processing services; customer servicesresponding to customers inquiries for others in the field of medical laboratory services; customer servicesresponding to customers inquiries for others in the field of medical diagnostic services
Class 38
providing access to an electronic exchange of medical records across a nationwide health information network to enable physicians to make informed medical recommendations
Class 42
medical research consulting; design and development of computer hardware and software for genetic testinggenetic sequencingbiochemical analysisnewborn screening and data processing; laboratory research in the fields of biochemistry and medical genetics; laboratory testing of materials; medical laboratory services; blood analysis services; DNA analysis services for scientific research purposes; providing medical research information in the field of patient clinical trials; providing an interactive web site featuring technology that enables users to accessmonitor and generate medical information and reports; providing information relating to pharmacology consultancy
Class 44
consulting services in the field of genetic testing for medical purposes; consulting services in the field of medical testing for diagnostic purposes; consulting services in the field of medical screening of infants for hereditary medical disorders; medical analysis services for diagnostic and medical purposesmedical analysis ofbloodbody fluidsextracellular tissue specimensstool samplesexhaled airbiopsy specimens and autopsy specimens; Medical laboratory testing of bloodbody fluidsextracellular tissue specimensstool samplesexhaled airbiopsy specimens and autopsy specimens all for diagnostic and medical purposes; medical information servicesreporting of patient authorized clinical testing results directly to doctors; medical analysis services of patient medical data for the diagnosis of cancer; providing medical information to doctors in the form of reports in the field of a medical diagnosis; providing healthcare information; providing medical information to patients in the field of pharmaceutical treatments; providing information relating to diagnostic properties of pharmaceuticals; providing medical information; providing health information to physicians about surgical instruments
Publications
History of USPTO decisions and trademark events.
76 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/27/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/27/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/27/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/27/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2021
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
03/04/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/04/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/22/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/22/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/29/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/04/2020
PUBO
PUBLISHED FOR OPPOSITION
08/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/15/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/18/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2019
GNRT
NON-FINAL ACTION E-MAILED
12/19/2019
CNRT
NON-FINAL ACTION WRITTEN
12/19/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/14/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/13/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/13/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
12/10/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2019
GNRT
NON-FINAL ACTION E-MAILED
06/12/2019
CNRT
NON-FINAL ACTION WRITTEN
06/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/21/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/21/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/26/2019
GNRT
NON-FINAL ACTION E-MAILED
04/26/2019
CNRT
NON-FINAL ACTION WRITTEN
04/26/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/27/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/26/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/28/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/28/2018
CNSI
SUSPENSION INQUIRY WRITTEN
09/28/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/27/2018
ALIE
ASSIGNED TO LIE
09/27/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/07/2018
GNSL
LETTER OF SUSPENSION E-MAILED
03/07/2018
CNSL
SUSPENSION LETTER WRITTEN
03/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/13/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/07/2017
GNSL
LETTER OF SUSPENSION E-MAILED
11/07/2017
CNSL
SUSPENSION LETTER WRITTEN
11/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/16/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/16/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/22/2017
GNSL
LETTER OF SUSPENSION E-MAILED
09/22/2017
CNSL
SUSPENSION LETTER WRITTEN
09/22/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/09/2017
GNRT
NON-FINAL ACTION E-MAILED
03/09/2017
CNRT
NON-FINAL ACTION WRITTEN
03/09/2017
DOCK
ASSIGNED TO EXAMINER
03/01/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2016
NWAP
NEW APPLICATION ENTERED
11/26/2016
Continuous trademark protection
Get notified about every new filing that threatens LIFELABS GENETICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.